HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.
Ontology highlight
ABSTRACT: Tumor metastasis is responsible for the high mortality rates in patients with hepatocellular carcinoma (HCC). Absent in melanoma 2 (AIM2) has been implicated in inflammation and carcinogenesis, although its role in HCC metastasis remains unknown. In the present study, we show that AIM2 protein expression was noticeably reduced in HCC cell lines and clinical samples. A reduction in AIM2 was closely associated with higher serum AFP levels, vascular invasion, poor tumor differentiation, an incomplete tumor capsule and unfavorable postsurgical survival odds. In vitro studies demonstrated that AIM2 expression was modulated by hepatitis B virus X protein (HBx) at transcriptional and post-translational levels. HBx overexpression markedly blocked the expression of AIM2 at mRNA and protein levels b
SUBMITTER: Chen SL
PROVIDER: S-EPMC5579341 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA